u133a oligonucleotide microarray platform (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
u133a oligonucleotide microarray platform
U133a Oligonucleotide Microarray Platform, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oligonucleotide+microarray+platform/pmc11483699-69-3-2
Average 90 stars, based on 1 article reviews
U133a Oligonucleotide Microarray Platform, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oligonucleotide+microarray+platform/pmc11483699-69-3-2
Average 90 stars, based on 1 article reviews
u133a oligonucleotide microarray platform - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Microarray:Article Title: Human Lung Project: Evaluating Variance of Gene Expression in the Human Lung Article Snippet: .. Similar to other published reports ( 35 , 46 , 47 ), we demonstrate that technical variability within the Article Title: Integrating microRNAs into a system biology approach to acute lung injury Article Snippet: .. For example, using the Article Title: Gender-Specific Gene Expression in Post-Mortem Human Brain: Localization to Sex Chromosomes Article Snippet: .. We profiled gene expression in male and female dorsolateral prefrontal cortex, anterior cingulate cortex, and cerebellum using the Article Title: Genomic approaches to the pathogenesis of hematologic malignancy. Article Snippet: Recent advances in genome technologies and computational biology have facilitated genome-wide views of hematologic malignancy.. In particular, comparative gene expression methods using DNA microarrays have allowed for the analysis of gene expression patterns in both primary patient material and model systems of hematopoietic development.. This review provides an overview of the basic technologies underlying these approaches and provides a summary of recent progress in the genome-wide molecular classification of human acute leukemias and lymphomas and of initial attempts to define oncogene-mediated transcriptional programs using DNA microarrays. Article Title: 239. Immunomodulation Is Necessary to Achieve Stable Expression after Retroviral Vector-Mediated Liver-Directed Gene Therapy to Adult Mice with MPS I Article Snippet: .. To determine if secondary genetic aberrations may contribute to aspects of the neurological defects, we are examining global gene expression in the striatum of wild type and HPRT knockout mice, using the Article Title: Development of Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology to Facilitate Drug Discovery and Translational Medicine Article Snippet: Biomarker identification has been a critical component in drug discovery and development.. Biomarkers have been utilized in several areas such as disease diagnosis, pharmacokinetics-pharmacodynamics (PK-PD) modeling, evaluation of efficacy and toxicity to guide both pre-clinical compound selection and clinical study of candidate compounds.. Recent advances in genomics and bioinformatics have created a new paradigm in the development of robust gene expression signature biomarkers, particularly for predicting toxicity and cancer drug responses. Quantitative Proteomics:Article Title: Integrating microRNAs into a system biology approach to acute lung injury Article Snippet: .. For example, using the Functional Assay:Article Title: Integrating microRNAs into a system biology approach to acute lung injury Article Snippet: .. For example, using the Gene Expression:Article Title: Gender-Specific Gene Expression in Post-Mortem Human Brain: Localization to Sex Chromosomes Article Snippet: .. We profiled gene expression in male and female dorsolateral prefrontal cortex, anterior cingulate cortex, and cerebellum using the Article Title: 239. Immunomodulation Is Necessary to Achieve Stable Expression after Retroviral Vector-Mediated Liver-Directed Gene Therapy to Adult Mice with MPS I Article Snippet: .. To determine if secondary genetic aberrations may contribute to aspects of the neurological defects, we are examining global gene expression in the striatum of wild type and HPRT knockout mice, using the Article Title: Development of Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology to Facilitate Drug Discovery and Translational Medicine Article Snippet: Biomarker identification has been a critical component in drug discovery and development.. Biomarkers have been utilized in several areas such as disease diagnosis, pharmacokinetics-pharmacodynamics (PK-PD) modeling, evaluation of efficacy and toxicity to guide both pre-clinical compound selection and clinical study of candidate compounds.. Recent advances in genomics and bioinformatics have created a new paradigm in the development of robust gene expression signature biomarkers, particularly for predicting toxicity and cancer drug responses. Knock-Out:Article Title: 239. Immunomodulation Is Necessary to Achieve Stable Expression after Retroviral Vector-Mediated Liver-Directed Gene Therapy to Adult Mice with MPS I Article Snippet: .. To determine if secondary genetic aberrations may contribute to aspects of the neurological defects, we are examining global gene expression in the striatum of wild type and HPRT knockout mice, using the Generated:Article Title: Development of Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology to Facilitate Drug Discovery and Translational Medicine Article Snippet: Biomarker identification has been a critical component in drug discovery and development.. Biomarkers have been utilized in several areas such as disease diagnosis, pharmacokinetics-pharmacodynamics (PK-PD) modeling, evaluation of efficacy and toxicity to guide both pre-clinical compound selection and clinical study of candidate compounds.. Recent advances in genomics and bioinformatics have created a new paradigm in the development of robust gene expression signature biomarkers, particularly for predicting toxicity and cancer drug responses. |
